Aventa Genomics
Biotechnology Research • 
Orlando, Florida, United States • 1-10 Employees
Company overview
| Headquarters | 6555 Sanger Rd, Suite 260, Orlando, Florida 32827, US |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
Key Contact at Aventa Genomics
Sean Dattoli
Director of Key Accounts
About Aventa Genomics
Aventa Genomics, LLC, a joint venture between Arima Genomics, Inc., and Protean BioDiagnostics, Inc., is a CLIA certified lab committed to improving patient outcomes by using 3D Genomics tools to reveal druggable targets and resolve diagnostic dilemmas. The company’s first laboratory developed test, the Aventa FusionPlus test, detects gene fusions, translocations and rearrangements across 361 genes in formalin-fixed, paraffin embedded (FFPE) tumor tissue. The Aventa FusionPlus test is available for ordering by physicians at www.aventagenomics.com.
Aventa Genomics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Aventa Genomics has never raised funding before.
Aventa Genomics Tech Stack
Discover the technologies and tools that power Aventa Genomics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Security
Programming languages
Blogs
Page builders
Analytics
SEO
Canada
South Africa
United KingdomFrequently asked questions
4.8
40,000 users
